Premature Discontinuation of Contraceptive Implants

  • STATUS
    Recruiting
  • End date
    Aug 31, 2023
  • participants needed
    600
  • sponsor
    University of Colorado, Denver
Updated on 27 August 2021

Summary

To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).

Description

Objective

To compare rates of etonogestrel implant discontinuation in implant initiators who are given advance provision of combined oral contraceptive pills (COCs) and a bleeding rescue regimen (COCR intervention) to participants given standard counseling (comparator).

Secondary Objectives:

To determine if participants initiating the contraceptive implant who are also provided COCR are more likely than participants receiving standard counseling to:

  1. report higher levels of satisfaction with their contraceptive implant at one year following initiation
  2. require less clinical follow-up and clinical resources in the year following initiation.

Details
Condition Contraceptive usage NOS
Treatment Ethinyl Estradiol / Norgestimate Oral Tablet
Clinical Study IdentifierNCT04828824
SponsorUniversity of Colorado, Denver
Last Modified on27 August 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

You are between ages of 14 to 22.9 years
Started etonogestrel implant for the first time and have never used the implant before

Exclusion Criteria

There is any contraindication to estrogen containing birth control
Desire of pregnancy in next 12 months
Plans to move from the area in next 12 months and is not able to come to the clinic
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note